Direct Answer
Revvity reports revenue across 2 business segments in its fiscal 2025 Form 10-K. Life Sciences is the largest, with $1.4 billion of revenue (50% of the total), followed by Diagnostics at $1.4 billion (50%).
How Does Revvity Make Money?
No single line supplies a majority of revenue: the largest, Life Sciences, is 50%, which spreads Revvity's exposure across several demand drivers. Between fiscal 2024 and 2025, Diagnostics grew fastest (+5.1%) and Life Sciences slowest (+2.3%), so the revenue mix tilts toward Diagnostics while that gap lasts.
| Segment | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| Life Sciences | $1.4 billion | $1.4 billion | 50.1% | 2.3% |
| Diagnostics | $1.4 billion | $1.4 billion | 49.9% | 5.1% |
What Does Revvity Sell?
Revvity also breaks revenue down by product and service line, which shows what customers pay for rather than how management organizes the business.
| Product or service | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| Product | $2.4 billion | $2.3 billion | 83.7% | 2.2% |
| Service | $466 million | $417 million | 16.3% | 11.8% |
What the Segment Figures Do Not Show
The rows above add up to 100% of Revvity's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.
Where These Numbers Come From
Every figure on this page is a value Revvity reported in the segment note and revenue disclosures of its Form 10-K filed February 24, 2026 (accession 0000031791-26-000012), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.
Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.
Frequently Asked Questions
What are Revvity's business segments?
In its fiscal 2025 Form 10-K, Revvity reports revenue for Life Sciences and Diagnostics.
Which part of Revvity brings in the most revenue?
Life Sciences, with $1.4 billion of revenue in fiscal 2025, or 50% of the total.
Where does Revvity report its segment results?
In the segment note to the financial statements in its Form 10-K, most recently filed February 24, 2026, alongside management's discussion of each segment's results.